STIMCONEConus Medullaris Stimulation With 5 Columns Lead Versus Medical Treatment in Refractory Pudendal Neuralgia: a Randomized, Open, Controlled, Multicenter Trial.
CMS group
+ OMM group
Syndromes de compression nerveuse+7
+ Maladies du système nerveux
+ Manifestations Neurologiques
Étude thérapeutique
Résumé
Date de début de l'étude : 30 septembre 2015
Date à laquelle le premier participant a commencé l'étude.In this national multicenter prospective open label trial, patients will be randomized 1:1 to experimental group (CMS group : Conus Medullaris Stimulation using pentapolar surgical lead, plus optimal medical management) or to control group (OMM group : optimal medical management alone) and followed for 12 months, in intention to treat. 42 patients suffering of refractory pudendal neuralgia will be included. Optimal medical management will be prescribed by algologists in both groups according to patient pain relief.
Protocole
Cette section fournit des détails sur le plan de l'étude, y compris la manière dont l'étude est conçue et ce qu'elle évalue.42 participants à inclure
Nombre total de participants que l'essai clinique vise à recruter.Traitement
Éligibilité
Les chercheurs recherchent des patients correspondant à une certaine description appelée critères d'éligibilité : état de santé général ou traitements antérieurs du patient.Tout sexe
Le sexe biologique des participants éligibles à s'inscrire.À partir de 18 ans
Tranche d'âge des participants éligibles à participer.Volontaires sains non autorisés
Indique si les individus en bonne santé et ne présentant pas la condition étudiée peuvent participer.Conditions
Pathologie
Critères
PRE-SCREENING CRITERIA: * Male or female aged 18 years or over * Pudendal neuralgia according published Nantes criteria * History of failure medical management : defined by HAS such as intractable pain after failure (by side effect, ineffective, or contraindication) at effective dose and combination of following treatment: * Pain treatment OMS analgesics Level I or II * Tricyclicantidepressant * Antiepileptics * Nerve block * Muscle relaxants * Physiotherapy * TENS (Transcutaneus electric nerve stimulation) * Psychobehavioral approach * Failure of pudendal nerve decompression surgery performed more than 12 months ago * Neuropathic pain according to criteria of the Neuropathic Pain Diagnostic Questionnaire (DN4). * Subjects able of giving informed consent * Affiliation with French social security system. * Average or maximum pain experienced greater than or equal to 5/10 on a visual analogue scale INCLUSION CRITERIA: * Average or maximum pain experienced greater than or equal to 50/100 on a visual analogue scale (average of data collected 7 days prior to the inclusion visit and recorded by the patient on the clinical diary) * Evaluation by multidisciplinary team including neuro-surgeons, algologists and psychologists performed, (if not already done in the previous year for algologists and psychologists) * Given informed consent. EXCLUSION CRITERIA: * Pregnant, or planning to become pregnant during the study (12months) * Adults under guardianship or trusteeship * Being treated or has been treated with spinal cord stimulation, subcutaneous or peripheral nerve stimulation, intrathecal drug delivery system. * Had pudendal nerve decompression surgery less than 12 months ago * Is suspected of substance abuse * Has unresolved major issues of secondary gain * Exhibits major psychiatric morbidity * Has life expectancy inferior to 5 years * Implant spinal cord stimulation surgery contraindication : * Magnetic resonnance imaging contraindication * History of coagulation disorder * Severe immunodepression, systemic, due to medicine drug intake or not (AIDS, transplanted, under anti TNF alpha treatment, …) * Current infection * Would be unable to operate the spinal cord stimulation equipment, undergo the study assessments or complete questionnaires or clinical diary, based on the opinion of the investigator * Unwilling to be treated with spinal cord stimulation, comply with study requirements. * Suffering from another neuropathic pain, or chronic pain, cancer, diabetic neuropathy * Patient with cardiac sentry stimulator or planned to be implanted with one
Plan de l'étude
Découvrez tous les traitements administrés dans cette étude, leur description détaillée et ce qu'ils impliquent.2 groupes d'intervention sont désignés dans cette étude
Cette étude ne comporte pas de groupe placebo.
Groupes de traitement
Groupe I
ExpérimentalGroupe II
Comparateur actifObjectifs de l'étude
Objectifs principaux
Objectifs secondaires
Centres d'étude
Ce sont les hôpitaux, cliniques ou centres de recherche où l'essai est conduit. Vous pouvez trouver le site le plus proche de vous ainsi que son statut.Cette étude comporte 7 sites
Clinic Catherine de Sienne
Nantes, FranceHôpital Foch
Suresnes, FranceLille University Hospital
Lille, France